Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

NCT04563299 is registered in ClinicalTrials.gov with Retina Vitreous Associates of Florida as lead sponsor.

NCT NCT04563299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04563299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
Lead sponsor
Retina Vitreous Associates of Florida
Phase
Phase 4
Overall status
Terminated
Start date
December 9, 2020
Completion date
February 14, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, neovascular age-related macular degeneration, retinal vein occlusion